Literature DB >> 15970032

Management and outcome of TB suspects admitted to the medical wards of a central hospital in Malawi.

Jeremy H Friend1, Shirin Mason, Anthony D Harries, Felix M Salaniponi, Florian Neuhann.   

Abstract

In a study conducted in the medical wards of Lilongwe Central Hospital, Malawi, 84 (18%) of 470 medical admissions were TB suspects. Of these, 21 (25%) had the diagnosis confirmed; the median length of time between admission and starting anti-TB treatment was 10 days. Of the remaining TB suspects, 24 (29%) had another diagnosis made, principally pneumonia, and 39 (46%) had no diagnosis made, with half of these patients dying under investigation in hospital. Improved and more rapid ways of managing TB suspects need to be found.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970032     DOI: 10.1258/0049475054037165

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Diagnostic management and outcomes of pulmonary tuberculosis suspects admitted to a central hospital in Malawi.

Authors:  L G Gawa; T Reid; M E Edginton; M Van Lettow; M Joshua; A D Harries
Journal:  Public Health Action       Date:  2011-09-21

2.  Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi.

Authors:  Kashmira S Chawla; Cecilia Kanyama; Abineli Mbewe; Mitch Matoga; Irving Hoffman; Jonathan Ngoma; Mina C Hosseinipour
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

3.  Understanding the barriers to setting up a healthcare quality improvement process in resource-limited settings: a situational analysis at the Medical Department of Kamuzu Central Hospital in Lilongwe, Malawi.

Authors:  Josephine Nana Afrakoma Agyeman-Duah; Antje Theurer; Charles Munthali; Noor Alide; Florian Neuhann
Journal:  BMC Health Serv Res       Date:  2014-01-02       Impact factor: 2.655

Review 4.  Confronting the scientific obstacles to global control of tuberculosis.

Authors:  Douglas B Young; Mark D Perkins; Ken Duncan; Clifton E Barry
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.